Retinal biomarkers provide "insight" into cortical pharmacology and disease
Christine TO Nguyen, Flora Hui, Jason Charng, Shajan Velaedan, Anna K van Koeverden, Jeremiah KH Lim, Zheng He, Vickie HY Wong, Algis J Vingrys, Bang V Bui, Magnus Ivarsson
PHARMACOLOGY & THERAPEUTICS | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2017
The retina is an easily accessible out-pouching of the central nervous system (CNS) and thus lends itself to being a biomarker of the brain. More specifically, the presence of neuronal, vascular and blood-neural barrier parallels in the eye and brain coupled with fast and inexpensive methods to quantify retinal changes make ocular biomarkers an attractive option. This includes its utility as a biomarker for a number of cerebrovascular diseases as well as a drug pharmacology and safety biomarker for the CNS. It is a rapidly emerging field, with some areas well established, such as stroke risk and multiple sclerosis, whereas others are still in development (Alzheimer's, Parkinson's, psychologi..View full abstract
Related Projects (2)
Awarded by Melbourne School of Health Sciences
Grant support: CTON: University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences Research Grant Support Scheme and Melbourne School of Health Sciences seed grant BVB: FT130100338.